tirzepatide trade name Eli Lilly launches weight-loss drug Mounjaro in India, beats Novo Nordisk to major market Mounjaro, Zepbound: Why two names

These events were usually mild or moderate

Of course this represents a huge market for any pharmaceutical company which can produce a safe and effective weight-loss treatment

As with any prescription, there are some potential risks, including an increased risk of the following:5 Heart disease Stroke Blood clots Breast cancer Uterine cancer Gallbladder disease Dementia39 Risks like these are part of why its important to maintain open communication with your doctor when considering or undergoing HRT

The second part is that beyond being accessible, theyre also where the communities that need the most are

5 You want the option of a higher dose